On the HCPLive news page, resources on the topics of disease- and specialty-specific medical news and expert insight can be found. Content includes articles, interviews, videos, podcasts, and breaking news on health care research, treatment, and drug development.
New Management and Treatment Guidelines Published for Hepatitis C Virus
The European Association for the Study of the Liver published their updated Clinical Practice Guidelines for the management of the hepatitis C virus, which includes updates regarding people who inject recreational drugs.
Pediatrics Group Cautions Against Raw Milk Consumption by Children, Pregnant Women
The American Academy of Pediatrics (AAP) has called for the sale of raw milk to be banned in the United States, as it warned that women, children, and infants should only consume pasteurized milk and milk products.
FDA to Consider Tighter Standards for Generic Epilepsy Drugs
Studies on drug pharmacokinetics in epilepsy patients are being conducted to help the US Food and Drug Administration (FDA) consider whether it needs to tighten bioequivalence rules for generic anti-epilepsy drugs (AEDs) and other medications that have narrow therapeutic windows.
Brintellix Tackles Cognitive Dysfunction Related to Major Depression
In addition to treating episodes of major depression, Brintellix (vortioxentine) has demonstrated superiority to placebo on measures of cognitive function in adult patients with major depressive disorder (MDD).
Smoking Cessation Therapy Does Not Interfere with Simultaneous Stimulant Addiction Treatment
A study published in The Journal of Clinical Psychiatry concludes that adults dependent on cocaine and/or methamphetamine who undergo stimulant addiction treatment does not detract from simultaneous smoking cessation therapy, and can even increase likelihood of quitting.
Increasing NMDA Glutamate Receptor Instead of Blocking It Produces Antidepressant-Like Effects
Results from animal models of depression and a human clinical trial show that enhancing, instead of blocking, the NMDA glutamate receptor can cause antidepressant-like effects.
Within a year of their diagnosis, nearly half of all first-line drug-treated MDD patients were also treated with a second-line therapy, a new study finds. Cymbalta leads the market in second-line therapy, used individually or as a combination, and Abilify is the leading atypical antipsychotic.
Experimental Compound May Reduce Joint Inflammation in Rheumatoid Arthritis
Researchers using mice models have shown that the compound SR2211, which targets a nuclear receptor that is a key regulator of TH17 cells, significantly reduces joint inflammation and erosion.
Thalidomide Extends Remission Duration in Children with Crohn's Disease
A new randomized, double-blind, placebo-controlled study of 56 children with Crohn's disease suggests pediatric patients treated with thalidomide have better rates of remission and response than those given placebo.